Bahrain approves AstraZeneca-Oxford COVID vaccine


The jab is the third granted emergency use within the Gulf nation after China’s Sinopharm and Pfizer/BioNtech.

Bahrain has granted emergency approval for the usage of a coronavirus vaccine produced by the UK’s AstraZeneca drug firm in collaboration with Oxford College.

The Nationwide Well being Regulatory Authority (NHRA) authorised the vaccine on Monday, in keeping with Bahrain’s state information company.

Approval was based mostly on a research carried out by NHRA in participation with the scientific analysis committee and the well being ministry immunization committee, Bahrain Information Company reported.

With a inhabitants of 1.6 million, the small nation has reported greater than 99,800 circumstances and 367 deaths, in keeping with a tally by Johns Hopkins College.

The Oxford-AstraZeneca shot is the third to be authorised within the Gulf nation. Bahrain has already given the inexperienced mild for emergency use to a Chinese language-made vaccine produced by Sinopharm, and it was the second nation worldwide to approve the Pfizer/BioNtech jab.

AstraZeneca, whose vaccine’s trials have proven to have a 70.4 percent efficacy rate, has come underneath growing scrutiny since final week when it knowledgeable European Union’s officers it will minimize deliveries by 60 p.c within the first quarter of the 12 months due to manufacturing issues.

Bahrain Information Company didn’t report the quantity or timing of the vaccine’s supply. The shot must be given in two jabs, 28 days aside.